Molecular abnormalities associated with endocrine tumors of the uterine cervix

Ignacio I. Wistuba, Bilue Thomas, Carmen Behrens, Naoyoshi Onuki, Guy Lindberg, Jorge Albores-Saavedra, Adi F. Gazdar

Research output: Contribution to journalArticle

60 Scopus citations

Abstract

Objective. We studied the molecular abnormalities involved in the pathogenesis of endocrine tumors of the uterine cervix. Methods. We obtained DNA from precisely microdissected archival tissue from 15 endocrine tumors of the uterine cervix, consisting of 5 carcinoids (1 typical, 4 atypical), 2 large cell neuroendocrine carcinomas, and 8 small cell carcinomas. We investigated the presence of high-risk (types 16 and 18) and intermediate- risk (types 31 and 33) human papilloma virus (HPV) sequences, TP53 and K-ras gene mutations, and loss of heterozygosity (LOH) at 9 genes/chromosomal regions, including 3p14.2/FHIT, 3p14-p21, 3p21, 3p22-p24, 5q21-q22/APC-MCC region, 9p21/CDKN2, 11q23/MEN1, 13q/RB, and 17p/TP53. Results. HPV sequences were detected in 8 (53%) tumors, HPV 16 in 2 cases, and HPV 18 in 2 cases. LOH at 9p21 (43%) and localized 3p deletions (47%) were the most frequent allelic losses found. Allelic losses at 5q21-q22/APC-MCC region, 11q23/MEN1, and 13q/RB were infrequent. TP53 gene mutations were detected in 7 (47%) tumors (1 atypical carcinoid and 6 carcinomas). HPV sequences were demonstrated in 4 of the 7 cases with TP53 gene mutations. No K-ras mutations were detected. Conclusion. The molecular changes present in endocrine tumors of the uterine cervix have distinct features. They incorporate those present in the neuroendocrine tumors of the lung (high frequency of TP53 gene abnormalities and 9p21 deletions) with those detected in squamous cell carcinomas of the cervix (high-risk HPV sequences and localized 3p deletions).

Original languageEnglish (US)
Pages (from-to)3-9
Number of pages7
JournalGynecologic oncology
Volume72
Issue number1
DOIs
StatePublished - Jan 1999

    Fingerprint

Keywords

  • Chromosome 3p
  • Loss of heterozygosity
  • Neuroendocrine tumors
  • TP53 gene mutations
  • Tumors of the uterine cervix

ASJC Scopus subject areas

  • Oncology
  • Obstetrics and Gynecology

Cite this

Wistuba, I. I., Thomas, B., Behrens, C., Onuki, N., Lindberg, G., Albores-Saavedra, J., & Gazdar, A. F. (1999). Molecular abnormalities associated with endocrine tumors of the uterine cervix. Gynecologic oncology, 72(1), 3-9. https://doi.org/10.1006/gyno.1998.5248